supply of I.V. Fluids COVID-19 (2020-21)= I.V.Dextrose 5% W / V I. P. , I.V.Dextrose 10% W / V I. P. , I.V. Dextrose 25% W / V I. P. , I.V.Dextrose 5% With Sodium Chloride 0.9 % W / V I.P. ( Dns ) , I.V.Compound Ringer Lactate I.P. ( Each 100 Ml. C

Sharing tender

supply of I.V. Fluids COVID-19 (2020-21)= I.V.Dextrose 5% W / V I. P. , I.V.Dextrose 10% W / V I. P. , I.V. Dextrose 25% W / V I. P. , I.V.Dextrose 5% With Sodium Chloride 0.9 % W / V I.P. ( Dns ) , I.V.Compound Ringer Lactate I.P. ( Each 100 Ml. Contains: Calcium Chloride I.P.0.027 Gm, Potassium Chloride I.P. 0.040 Gm., Sodium Chloride I.P. 0.600 Gm, Sodium Lactate I.P. 0.25 Gm, Water For Injection Q. S. ) , I. V. Ringers Lactate ( Sodium Lactate, Compound Solution ) Each 100Ml To Contain: Lactic Acid 0.24 Ml., Sod.Chl. 0.6 Gm, Potassium Chloride 0.04 Gm, Calcium Chloride 0.027 Gm. Water For Injection Q.S. Calculated Osmolarity –280 Mos / L ( Approx ) Concentration Of Electrolytes ( In Moles / Lit. ) - Sodium 131, Potassium 5, Calcium 2, Bicarbonate ( As Lactate ) 29, Chloride 111.Affs / Bfs / Ffs Technology , I.V.Sodium Chloride 0.9% W / V I.P. , I.V.Sodium Chloride 0.9% W / V I.P. , I.V.Sodium Chloride 0.45% W / V , I.V.Ciprofloxacin 2Mg / Ml , I.V.Metronidazole5 Mg / Ml , Fluconazole2 Mg / Ml , Levofloxacin 5Mg / Ml , Linezolide 200 Mg / 100 Ml , Hydroxyethyl Starch ( 200 / 0.5 ) 6 % , Linezolide 2 Mg / Ml